Abstract | BACKGROUND: METHODS AND RESULTS: CONCLUSIONS: Optimal use of most standard hospital-based AMI treatment strategies, especially combined strategies, would be cost effective in China. However, because so many AMI deaths occur outside of the hospital in China, the overall impact on preventing CHD deaths was projected to be modest.
|
Authors | Miao Wang, Andrew E Moran, Jing Liu, Pamela G Coxson, Paul A Heidenreich, Dongfeng Gu, Jiang He, Lee Goldman, Dong Zhao |
Journal | Circulation. Cardiovascular quality and outcomes
(Circ Cardiovasc Qual Outcomes)
Vol. 7
Issue 1
Pg. 78-85
(Jan 2014)
ISSN: 1941-7705 [Electronic] United States |
PMID | 24425706
(Publication Type: Comparative Study, Journal Article, Research Support, N.I.H., Extramural, Research Support, Non-U.S. Gov't)
|
Chemical References |
- Adrenergic beta-Antagonists
- Angiotensin-Converting Enzyme Inhibitors
- Hydroxymethylglutaryl-CoA Reductase Inhibitors
- Heparin
- Clopidogrel
- Ticlopidine
- Aspirin
|
Topics |
- Adrenergic beta-Antagonists
(economics, therapeutic use)
- Adult
- Aged
- Aged, 80 and over
- Angiotensin-Converting Enzyme Inhibitors
(economics, therapeutic use)
- Aspirin
(therapeutic use)
- China
(epidemiology)
- Clopidogrel
- Computer Simulation
- Coronary Disease
(epidemiology, mortality)
- Cost-Benefit Analysis
- Electrocardiography
- Heparin
(economics, therapeutic use)
- Hospital Mortality
- Humans
- Hydroxymethylglutaryl-CoA Reductase Inhibitors
(economics, therapeutic use)
- Markov Chains
- Middle Aged
- Myocardial Infarction
(drug therapy, economics, epidemiology)
- Percutaneous Coronary Intervention
- Ticlopidine
(analogs & derivatives, economics, therapeutic use)
|